Thymulin (FTS)

Thymulin is a nonapeptide hormone primarily synthesized by thymic epithelial cells, playing a central role in the differentiation and maturation of T-lymphocytes. Its biological activity is strictly dependent on the presence of zinc, which forms a bioactive zinc-thymulin complex required for binding to high-affinity receptors on target cells (Bach, 1983; Dardenne et al., 1982). Beyond its immunological functions, thymulin acts as a key mediator in the neuroendocrine-immune axis, influencing the hypothalamic-pituitary-adrenal (HPA) axis and the secretion of hormones like prolactin and growth hormone (Safieh-Garabedian et al., 2000). Clinically, thymulin levels serve as a biomarker for thymic endocrine function, with deficiencies observed in aging, DiGeorge syndrome, and various autoimmune or infectious diseases (Mocchegiani et al., 1995). Therapeutic interest in thymulin focuses on its potential to restore immune function in immunodeficient states and its potent anti-inflammatory and analgesic properties. These effects are largely mediated through the inhibition of pro-inflammatory cytokines and the modulation of the peripheral nervous system (Hadidi et al., 2003). As a drug target, thymulin is often addressed through synthetic peptide analogs or by ensuring adequate zinc bioavailability to maintain its active conformation. Despite its potential, the clinical use of thymulin is challenged by its short half-life in the bloodstream due to rapid degradation by plasma peptidases.

Other names

Facteur Thymique SériqueFTSSerum Thymic FactorZinc-Thymulin

Activation of high-affinity thymulin receptors on T-lymphocytes to induce maturation; modulation of the neuroendocrine-immune axis; inhibition of pro-inflammatory cytokine production (Bach, 1983; Safieh-Garabedian et al., 2000).